new concerns about cardiac risk with Meridia
January 2010
See updated information from FDA and Health Canada concerning the withdrawal of Meridia from the U.S. and Canadian markets
You'll hear new concerns about cardiac risk with Meridia.
The manufacturer tried to show that Meridia (sibutramine) could improve cardiovascular outcomes in high-risk patients...by helping them lose weight.
But instead they found a HIGHER risk of heart attacks and strokes in patients taking Meridia.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote